FDA Grants Accelerated Approval to Lilly Cancer Drug February 1, 2023 AutoBot News 0 FDA granted accelerated approval to Eli Lilly and Company’s pirtobrutinib for treatment of relapsed or refractory mantle cell lymphoma.